Blueprint Medicines Corp (NASDAQ:BPMC) People

Blueprint Medicines Corp

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Charles A Rowland Jr
Other companies: Generation Bio Co (Director · Since at least Jun 11, 2020); Viking Therapeutics, Inc. (Director · Since at least Jul 1, 2017); Orchard Therapeutics PLC (Director · Jan 1, 2020 – Jan 24, 2024 · Past); Nabriva Therapeutics AG (Director · Dec 30, 2016 – Aug 3, 2022 · Past); Vitae Pharmaceuticals Inc (Director · Sep 24, 2014 – Oct 25, 2016 · Past); BIND Therapeutics Inc (Director · May 28, 2014 – Jun 21, 2016 · Past); Idenix Pharmaceuticals Inc (Director · Jun 6, 2013 – Aug 5, 2014 · Past); Viropharma Inc (VP, Chief Financial Officer · Oct 20, 2008 – Jan 24, 2014 · Past)
Director · Apr 30, 2015 – Jun 2, 2021 · Past
Habib Joseph Dable
Other companies: Tyra Biosciences, Inc. (Director · Since at least Apr 16, 2026); SpyGlass Pharma, Inc. (Director · Since at least Feb 5, 2026); Relay Therapeutics, Inc. (Director · Since at least Nov 4, 2025); Day One Biopharmaceuticals Inc (Director · Since at least Jan 17, 2024); PepGen Inc. (Director · Since at least Sep 20, 2022); Jade Biosciences, Inc. (Director · Jul 10, 2023 – Jun 5, 2024 · Past); Albireo Pharma Inc (Director · Aug 8, 2022 – Mar 2, 2023 · Past); Acceleron Pharma Inc (CEO and President, Director · Jan 4, 2021 – Nov 19, 2021 · Past)
Director · Since at least Jun 23, 2022
Mark Alan Goldberg
Other companies: Audentes Therapeutics Inc (Director · Dec 11, 2017 – Jan 15, 2020 · Past); aTyr Pharma, Inc. (Director · May 6, 2015 – May 9, 2017 · Past); Crescent Biopharma, Inc. (Director · Jul 8, 2014 – May 1, 2024 · Past); Aceragen Inc. (Director · Jan 7, 2014 – Jun 23, 2022 · Past); ImmunoGen Inc (Director · Nov 8, 2011 – Feb 12, 2024 · Past); Synageva BioPharma Corp (EVP, Medical & Reg. Strategy · Nov 2, 2011 – Sep 19, 2014 · Past)
Director · Since at least Jun 25, 2015
Daniella Beckman
Other companies: Upstream Bio, Inc. (Member, Board of Directors · Since at least Oct 10, 2024); Tango Therapeutics, Inc. (Chief Financial Officer · Since at least Aug 10, 2021); Vor Biopharma Inc. (Chair of the Audit Committee · Since at least Feb 4, 2021); 5 01 Acquisition Corp (Director · Oct 13, 2020 – Oct 16, 2020 · Past); Translate Bio Inc (Director · Jun 18, 2019 – Sep 14, 2021 · Past)
Director · Since at least Dec 8, 2021
Alexis Borisy
Other companies: Parabilis Medicines, Inc. (Lead Independent Director; Chairman, Nextech Invest; Chairman, Curie.Bio · Since at least Jun 9, 2026); Revolution Medicines, Inc. (Director · Since at least Jun 26, 2025); Relay Therapeutics, Inc. (Director · Since at least Jun 6, 2025); Tango Therapeutics, Inc. (Director · Since at least Jun 5, 2025)
Director · Since at least Jun 18, 2025
Lonnel Coats
Other companies: Mineralys Therapeutics, Inc. (Board Member · Since at least Oct 19, 2026); Relay Therapeutics, Inc. (Director · Since at least Nov 4, 2025); Verve Therapeutics Inc (Director · Since at least Aug 8, 2022); Lexicon Pharmaceuticals, Inc. (Chief Executive Officer, Director · Jul 7, 2014 – Feb 28, 2024 · Past)
Director · Since at least Feb 3, 2016
Jeffrey Albers
Other companies: Spyre Therapeutics, Inc. (Director · Since at least Nov 22, 2023); Kymera Therapeutics, Inc. (Director · Since at least Aug 20, 2020); Dianthus Therapeutics, Inc. (Director · Jun 20, 2018 – Jun 28, 2022 · Past)
Director · Since at least Apr 30, 2015
Lynn Seely
Other companies: AbCellera Biologics Inc. (Director · Since at least Jun 30, 2026); Lyell Immunopharma, Inc. (President and CEO, Director · Since at least Jun 16, 2021); Myovant Sciences Ltd (Principal Executive Officer, Director · Apr 5, 2019 – Apr 3, 2020 · Past)
Director · Since at least Jun 19, 2019
Christina Rossi
Other companies: CG Oncology, Inc. (Biopharmaceutical Executive & Board Member · Since at least Nov 24, 2025); Xilio Therapeutics, Inc. (Director · Since at least Oct 21, 2021)
Chief Operating Officer · Since at least Oct 29, 2018
Kyle Kuvalanka
Other companies: Aktis Oncology, Inc. (Chief Financial Officer · Since at least Jan 8, 2026); Syros Pharmaceuticals, Inc. (Chief Operating Officer · Jun 29, 2016 – Feb 10, 2017 · Past)
Chief Business Officer · Apr 30, 2015 – Apr 30, 2015 · Past
Philina Lee
Other companies: DBV Technologies SA (Board Member · Since at least Oct 30, 2025); Fusion Pharmaceuticals Inc (Director · Feb 11, 2021 – Jun 4, 2024 · Past)
Chief Commercial Officer · Since at least Apr 4, 2022
Becker Hewes
Other companies: Damora Therapeutics, Inc. (Chief Medical Officer · Since at least Jan 5, 2026)
Chief Medical Officer · Since at least Jan 11, 2021
Anthony L BoralChief Medical Officer · Nov 6, 2017 – Dec 14, 2020 · Past
Ariel HurleyPrincipal Accounting Officer · Since at least May 5, 2025
Christopher K MurrayCHIEF TECHNICAL OPERATIONS · Oct 10, 2017 – Mar 7, 2024 · Past
Debra Durso-BumpusChief People Officer · Since at least Aug 24, 2022
Marion DorschChief Scientific Officer · Nov 21, 2016 – Feb 22, 2021 · Past
Percy H CarterChief Scientific Officer · Since at least Jun 6, 2022